Eyenovia Inc (EYEN) Stock
EYEN is no longer traded. Eyenovia was delisted from the Nasdaq in July 2025.
Prices on this page are historical; the last trade was July 3, 2025 at $14.36.
Eyenovia stock price history
EYEN final trading statistics
- Final close
- $14.36
- Final trading day
- Jul 3, 2025
- Market cap at delisting
- $73.30M
- Shares outstanding
- 5.10M
- Final 52-week range
- $0.03 – $17.18
- Avg. volume (final 3 mo.)
- 4,461,815
- All-time high (split-adj.)
- $796.00 · Jan 2018
- All-time low (split-adj.)
- $0.92 · Apr 2025
- Return since IPO
- -98.2%
- Beta
- 1.00
- Book value / share
- -$3.43
- Price / book
- -4.18
Eyenovia annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $57.3K | -$49.8M | -$16.99 |
| FY2023 | $3.8K | -$27.3M | -$0.67 |
| FY2022 | $10.00M | -$27.7M | -$0.84 |
| FY2021 | $14.00M | -$13.0M | -$0.51 |
| FY2020 | $2.00M | -$19.7M | -$0.96 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Eyenovia Inc
Eyenovia, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company offers Optejet, a topical ophthalmic medication dispensing platform services. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi; and agreement with Formosa Pharmaceuticals. Inc. for Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was founded in 2014 and is based in New York, New York.
Eyenovia stock FAQ
What happened to Eyenovia stock?
Eyenovia stock was delisted from the Nasdaq. Its final close was $14.36 on July 3, 2025.
Is EYEN stock still trading?
No. EYEN was delisted from the Nasdaq in July 2025 and no longer trades on a U.S. exchange.
What was the last price of EYEN stock?
EYEN closed at $14.36 on its final trading day, July 3, 2025, for a market value of about $73.30M.
What were Eyenovia's revenue and earnings in its last full fiscal year?
Eyenovia reported revenue of $57.3K and net income of -$49.8M in fiscal 2024, its last full year as a public company.
When did Eyenovia go public?
Eyenovia Inc stock began trading on January 25, 2018.